These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29773282)

  • 1. [Congenital ichtyosis to have its own biotherapies?].
    Dereure O
    Ann Dermatol Venereol; 2018; 145(6-7):471-472. PubMed ID: 29773282
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficiency of Ustekinumab in Crohn's Disease with Severe Psoriasiform Rash Induced by Biotherapies in an Adolescent.
    Bertrand V; El Haite A; Carré D
    Pediatr Dermatol; 2017 Jul; 34(4):e214-e215. PubMed ID: 28436109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal recessive congenital ichthyosis due to homozygous variants in NIPAL4 with a dramatic response to ustekinumab.
    Poulton C; Gration D; Murray K; Baynam G; Halbert A
    Pediatr Dermatol; 2019 Nov; 36(6):1002-1003. PubMed ID: 31532840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab.
    Paller AS; Czarnowicki T; Renert-Yuval Y; Holland K; Huynh T; Sadlier M; McAleer MA; Tran G; Geddes GC; Irvine AD; Guttman-Yassky E
    J Am Acad Dermatol; 2018 Mar; 78(3):498-505.e2. PubMed ID: 29066275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ustekinumab as therapy for psoriasis in a 2-year-old girl.
    Min MS; Shroff A; Rose S; Lebwohl M; Guttman-Yassky E
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e109-e110. PubMed ID: 26377248
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of lichen planopilaris to respond to ustekinumab.
    Webster G
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ustekinumab for hidradenitis suppurativa: a case report.
    Santos-Pérez MI; García-Rodicio S; Del Olmo-Revuelto MA; Pozo-Román T
    Actas Dermosifiliogr; 2014 Sep; 105(7):720-2. PubMed ID: 24308927
    [No Abstract]   [Full Text] [Related]  

  • 8. Clearance of annular pustular psoriasis with ustekinumab.
    Schnabel V; Broekaert SMC; Schön MP; Mössner R
    Eur J Dermatol; 2017 Jun; 27(3):296-297. PubMed ID: 28202422
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.
    Low ZM; Mar A
    Australas J Dermatol; 2018 May; 59(2):131-134. PubMed ID: 29205260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of superimposed linear psoriasis to ustekinumab: A case report.
    Weng HJ; Tsai TF
    Indian J Dermatol Venereol Leprol; 2017; 83(3):392-396. PubMed ID: 28366906
    [No Abstract]   [Full Text] [Related]  

  • 11. Brodalumab versus ustekinumab in psoriasis.
    Fioranelli M; Roccia MG; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):298. PubMed ID: 26627075
    [No Abstract]   [Full Text] [Related]  

  • 12. Five-year experience with Ustekinumab for psoriasis: real-life data of a single centre.
    Vergou T; Moustou AE; Antoniou C
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e40-e41. PubMed ID: 27038363
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
    Fujita Y; Shinkuma S; Nomura T; Shimizu H
    Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful response of refractory type I adult-onset pityriasis rubra pilaris with ustekinumab and acitretin combination therapy.
    Byekova Y; Sami N
    J Dermatol; 2015 Aug; 42(8):830-1. PubMed ID: 25982628
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian multicentre retrospective study.
    Shahbaz A; Qiang J; Marinas JEC; Kim WB; Greaves S; Yeung J
    Br J Dermatol; 2017 Jul; 177(1):297-298. PubMed ID: 27639251
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnancy during Ustekinumab Treatment for Severe Psoriasis.
    Rocha K; Piccinin MC; Kalache LF; Reichert-Faria A; Silva de Castro CC
    Dermatology; 2015; 231(2):103-4. PubMed ID: 25790947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
    Megna M; Napolitano M; Balato N; Monfrecola G; Villani A; Ayala F; Balato A
    Clin Exp Dermatol; 2016 Jul; 41(5):564-6. PubMed ID: 27028505
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection.
    Saeki H; Ito T; Hayashi M; Fukuchi O; Umezawa Y; Nobeyama Y; Teruya K; Nakagawa H
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1653-5. PubMed ID: 24754476
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
    Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
    Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester.
    Sheeran C; Nicolopoulos J
    Australas J Dermatol; 2014 Aug; 55(3):235-6. PubMed ID: 25117169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.